Experimental vaccine 1

BIOLOGICAL2 trials

Sponsors

Sinovac Research and Development Co., Ltd., National Vaccine and Serum Institute, China

Conditions

COVID-19COVID-19 Pneumonia

Phase 1

Phase I Clinical Trial of GEN2-Recombinant COVID-19 Vaccine (CHO Cells) in Healthy People Aged 18 and Above

CompletedNCT05408312

National Vaccine and Serum Institute, ChinaCOVID-19 Pneumonia

Start: 2022-06-18End: 2024-02-28Updated: 2026-01-16

Phase 4

Safety and Immunogenicity Study of Booster Vaccination With COVID-19 Vaccine (Vero Cell),Inactivated From Different Manufactures for Prevention of COVID-19

SuspendedNCT05165732

Sinovac Research and Development Co., Ltd.COVID-19

Start: 2022-12-20End: 2023-08-20Target: 480Updated: 2022-08-11